Article Information
History
- December 7, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Eleanor C. Semmes1,2,3,
- Itzayana G. Miller2,7,
- Jennifer A. Jenks1,2,
- Courtney E. Wimberly3,4,
- Stella J. Berendam2,
- Melissa J. Harnois2,
- Helen Webster2,
- Jillian H. Hurst3,5,
- Joanne Kurtzberg5,6,
- Genevieve G Fouda2,3,
- Kyle M. Walsh3,4 and
- Sallie R. Permar2,3,7,*
- 1Medical Scientist Training Program, Department of Molecular Genetics and Microbiology, Duke University, Durham, NC, USA
- 2Duke Human Vaccine Institute, Duke University, Durham, NC, USA
- 3Duke Children’s Health & Discovery Initiative, Duke University, Durham, NC, USA
- 4Department of Neurosurgery, Duke University, Durham, NC, USA
- 5Department of Pediatrics, Duke University, Durham, NC, USA
- 6Carolinas Cord Blood Bank, Duke University Medical Center, Durham, NC, USA
- 7Department of Pediatrics, Weill Cornell School of Medicine, New York City, NY, USA
- ↵*Corresponding author: Sallie R. Permar, MD, PhD Email: sallie.permar{at}med.cornell.edu
Posted December 07, 2021.
Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection
